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Dermatomyositis (DM) and polymyositis (PM) are part of the idiopathic inflammatory myopathies, a heterogeneous group of chronic systemic autoimmune 
myopathies, associated with high morbidity and functional disability1. In 1975, Bohan and Peter published a classic article that suggested a set of criteria to aid in the 
diagnosis and classification of DM and PM2. Of the 5 criteria, 4 related to the muscle disease: (1) progressive proximal symmetrical weakness, (2) elevated muscles 
enzymes, (3) an abnormal electromyography, and (4) an abnormal muscle biopsy, while the fifth was the presence of compatible cutaneous disease. It was felt that 
DM differed from PM only by the presence of cutaneous disease2. Recent studies of the myopathy suggests that the myopathies in DM and PM present different 
epidemiological, histological, immunohistochemical, pathological, and clinical characteristics, as well as different disease courses1.  
 
53 years old female patient without relevant past clinical history 
 
Attends to Emergency Department with a three month history of: 
generalized rash with pruritus: 
• predominantly in the trunk and upper limbs 
• extending to the face (close to the scalp), thighs and knees 
• associated with: 
-- lip swelling 
-- asthenia 
-- muscle fatigue 
-- difficulty elevating the arms above shoulder level 
  
Physical examination : 
- V shaped rash in the upper torso; 
- violaceous papular rash in the knees, lateral region of thighs, upper limbs, and nose; 
 
 Blood analysis: myoglobin of 312 ng/mL (without other abnormalities).  
 
After admission:  
mild heliotrope 
muscle weakness of the pelvic and shoulder girdles 
 
Initial study: 
 increased muscle enzymes 
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 Prednisolone 1 mg/kg/day 
 
 
• rapid improvement of skin lesions and muscle symptoms; 
• normalization of the serum muscle enzyme 
 
 Functional rehabilitation was started  
 Regular follow-up as an outpatient in the Autoimmune Diseases clinic 
 
 
Dermatomyositis is a condition primarily of the skin and muscles, but other systemic features may occur. Dermatomyositis may also have inflammatory muscle 
diseases (polymyositis or inclusion body myositis)2. The prognosis is good except for patients with associated malignancy, those with severe weakness and those with 
cardiac dysfunction, interstitial lung disease or the presence of a myositis-specific autoantibody other than Mi-22. 
The correct interpretation of the clinical and analytical changes in an early stage enabled a fast diagnosis and a rapid initiation of therapy, minimizing the 
impact on the patients general health and quality of life. 
 
